Federal funding for cancer research has led to significant advances in cancer prevention, detection, diagnosis, treatment, and quality of life for patients, leading to a record 15.5 million survivors of cancer alive in the United States today.
Virtually every American has been touched by cancer, and voters in the United States overwhelmingly support greater investment in cancer research. ASCO’s National Cancer Opinion Survey found that 73% of Americans support the government spending more on finding treatments and cures for cancer—even if it means higher taxes or adding to the deficit.
ASCO is urging Congress to continue building on its investment in cancer research to maintain the pace of scientific discovery and continue progress against cancer.
Read about the impact of federal funding in cancer research in “Setting the Pace of Progress: U.S. Investment in Cancer Research Saves Lives.”
- Visit our Cancer Progress Timeline – recently updated to highlight advances supported by federally funded research. This data-rich, interactive resource provides a historical overview of major advances in cancer research and care spanning 170 years.
- Read about research projects that received federal funding in our latest Clinical Cancer Advances report.
Federally Funded Research Badge Download
ASCO has created a badge to highlight research that has received federal funding. This badge is featured in the Cancer Progress Timeline and Clinical Cancer Advances reports.
Free use of badge with following tagline: "The Federally Funded Research logo is a trademark of the American Society of Clinical Oncology. Used with permission. For more information, visit the Federally Funded Cancer Research homepage."
Review the Trademark License Agreement before downloading. You may begin using the badge immediately; right-click to save to your hard drive.
- National Cancer Institute: NCI’s Role in Cancer Research. https://www.cancer.gov/research/nci-role
- From humble beginnings to success in the clinic: Chimeric antigen receptor-modified T-cells and implications for immunotherapy. Experimental Biology and Medicine 2015; 240: 1087–1098.
- Memorial Sloan Kettering Cancer Center. CAR T Cells: Timeline of Progress. https://www.mskcc.org/timeline/car-t-timeline-progress
- National Cancer Institute: Olaratumab Approved to Treat Advanced Soft Tissue Sarcoma. https://www.cancer.gov/news-events/cancer-currents-blog/2016/fda-olaratu...
- National Cancer Institute: 2015-2016 SPORE Advances. https://trp.cancer.gov/spore_advances/default.htm
- FDA: Drug Approval Process. https://www.fda.gov/downloads/drugs/resourcesforyou/consumers/ucm284393.pdf
- National Cancer Institute: Less Chemotherapy May Be Best Choice for Some Patients with Colon Cancer, Study Shows. https://www.cancer.gov/news-events/cancer-currents-blog/2017/adjuvant-ch...
- National Cancer Institute: National Lung Screening Trial. https://www.cancer.gov/types/lung/research/nlst
- Food and Drug Administration: Development & Approval Process (Drugs). https://www.fda.gov/drugs/developmentapprovalprocess/